marks published for opposition - U.S. Patent and Trademark Office

TM 290 OFFICIAL GAZETTE APRIL 16, 2002
CLASS 5—(Continued).
SN 78-041,761. ENRICH CORPORATION, THE, OREM, UT.
FILED 1-4-2001.
CM PLEX
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE "CM", APART FROM THE MARK AS SHOWN.
FOR NUTRITIONAL SUPPLEMENTS; NUTRITIONAL
PREPARATIONS, NAMELY, VITAMINS, MINERALS
AND HERBS IN CAPSULE, TABLET AND POWDER
FORM FOR USE TO SUPPORT HEALTHY JOINTS
AND CONNECTIVE TISSUES; PHARMACEUTICAL
PREPARATIONS NAMELY VITAMINS, MINERALS
AND HERBS FOR USE IN THE PROMOTION OF
NORMAL JOINTS AND CONNECTIVE TISSUE, AND
TO LUBRICATE THE JOINTS TO INCREASE MOBILITY
ANDRANGEOFMOVEMENT(U.S.CLS.6,18,44,46,51
AND 52).
SN 78-044,320. NOVARTIS AG, BASEL, SWITZERLAND,
FILED 1-22-2001.
ZALABEL
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF DISORDERS OF THE CENTRAL
NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE
CARDIO-VASCULAR SYSTEM, THE RESPIRATORY
SYSTEM, THE MUSCULO-SKELETAL SYSTEM, FOR
THE TREATMENT OF INFLAMMATORY DISORDERS,
AND FOR USE IN DERMATOLOGY AND ONCOLOGY
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-044,322. NOVARTIS AG, BASEL, SWITZERLAND,
FILED 1-22-2001.
ZELMABEL
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF DISORDERS OF THE CENTRAL
NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE
CARDIO-VASCULAR SYSTEM, THE RESPIRATORY
SYSTEM, THE MUSCLO-SKELETAL SYSTEM, FOR
THE TREATMENT OF INFLAMMATORY DISORDERS,
AND FOR USE IN DERMATOLOGY AND ONCOLOGY
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-049,128. EAST WEST MEDICAL, LLP, WAYZATA, MN.
FILED 2-19-2001.
QUITBEADS
FOR TRANSDERMAL, SELF-ADHESIVE PATCHES
BEARING SMALL BEADS FOR STIMULATION OF
ACUPRESSURE OR THERAPY POINTS ON THE WEAR-
ER FOR USE IN THE TREATMENT OF CRAVINGS,
WITHDRAWAL, AND OTHER SYMPTOMS ASSO-
CIATED WITH CHEMICAL DEPENDENCY, SMOKING
CESSATION, ALCOHOL DEPENDENCY AND OTHER
ADDITIONS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
CLASS 5—(Continued).
SN 78-049,878. BRISTOL-MYERS SQUIBB COMPANY, NEW
YORK, NY. FILED 2-23-2001.
DISREVA
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF CARDIOVASCULAR DISEASES, CEN-
TRAL NERVOUS SYSTEM DISEASES AND DISORDERS,
STROKE, CANCER, INFLAMMATION AND INFLAM-
MATORY DISEASES, RESPIRATORY AND INFECTIOUS
DISEASES AND AUTO-IMMUNE DISEASES (U.S. CLS. 6,
18, 44, 46, 51 AND 52).
SN 78-049,883. BRISTOL-MYERS SQUIBB COMPANY, NEW
YORK, NY. FILED 2-23-2001.
OBLIST
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF CARDIOVASCULAR DISEASES, CEN-
TRAL NERVOUS SYSTEM DISEASES AND DISORDERS,
STROKE, CANCER, INFLAMMATION AND INFLAM-
MATORY DISEASES, RESPIRATORY AND INFECTIOUS
DISEASES AND AUTO-IMMUNE DISEASES (U.S. CLS. 6,
18, 44, 46, 51 AND 52).
SN 78-052,876. NOXELL CORPORATION, HUNT VALLEY,
MD. FILED 3-13-2001.
VITALHBOOSTERS
FOR COMBINATION OF VITAMINS FOR USE IN
COSMETICS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-054,283. PHARMACIA CORPORATION, PEAPACK,
NJ. FILED 3-21-2001.
PLATO
FOR PHARMACEUTICAL PREPARATIONS, NAMELY
PREPARATIONS FOR THE TREATMENT OF INFEC-
TIOUS DISEASES, CANCER, DIABETES, OPHTHALMO-
LOGIC CONDITIONS AND DISEASES, CENTRAL
NERVOUS SYSTEM DISEASES AND DISORDERS, PAR-
KINSON’S DISEASE, CARDIOVASCULAR DISEASES
AND CONDITIONS, MIGRAINES, URINARY TRACT
INFECTIONS, URINARY BLADDER INFECTIONS,
ANTI-INFLAMMATORY PHARMACEUTICAL PRE-
PARATIONS, AND HORMONAL PREPARATIONS (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).